Pamela Holland, PhD

Senior Vice President, Biology at InduPro

Speaker

Pamela Holland, PhD, is SVP of Biology at InduPro, overseeing pipeline development. Prior to InduPro, she was SVP of Research at Alpine Immune Sciences, overseeing oncology and autoimmunity programs. Prior to Alpine, she was VP, Cancer Biology at Surface Oncology in Cambridge MA, playing key roles in developing the early Surface pipeline and establishing a multi-program strategic partnership with Novartis. Prior to Surface, Dr. Holland held roles of increasing responsibility in oncology research at Amgen, working on TNF-receptor superfamily members for oncology and cancer immunotherapy. Dr. Holland obtained her PhD from the University of Washington/Fred Hutchinson Cancer Research Center followed by a post-doctoral position at Immunex. Prior to graduate school, she was a key contributor to the development of PCR applications and TaqMan™at Cetus Corporation. She is a co-inventor on all TaqMan patents and was the lead author on the first publication describing TaqMan in 1991.